Palvella Therapeutics (PVLA) Company Overview

Profile

Full Name:

Palvella Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 2, 2015

Indexes:

Not included

Description:

Palvella Therapeutics focuses on developing treatments for rare genetic diseases, particularly those affecting the skin. The company aims to improve the quality of life for patients through innovative therapies.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 20, 25 Canaccord Genuity
Buy
Feb 11, 25 HC Wainwright & Co.
Buy
Feb 5, 25 TD Cowen
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 3, 25 HC Wainwright & Co.
Buy
Dec 26, 24 HC Wainwright & Co.
Buy

Screeners with PVLA included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Palvella Therapeutics?
  • Does Palvella Therapeutics pay dividends?
  • What sector is Palvella Therapeutics in?
  • What industry is Palvella Therapeutics in?
  • What country is Palvella Therapeutics based in?
  • When did Palvella Therapeutics go public?
  • Is Palvella Therapeutics in the S&P 500?
  • Is Palvella Therapeutics in the NASDAQ 100?
  • Is Palvella Therapeutics in the Dow Jones?
  • When does Palvella Therapeutics report earnings?
  • Should I buy Palvella Therapeutics stock now?

What is the ticker symbol for Palvella Therapeutics?

The ticker symbol for Palvella Therapeutics is NASDAQ:PVLA

Does Palvella Therapeutics pay dividends?

No, Palvella Therapeutics does not pay dividends

What sector is Palvella Therapeutics in?

Palvella Therapeutics is in the Healthcare sector

What industry is Palvella Therapeutics in?

Palvella Therapeutics is in the Biotechnology industry

What country is Palvella Therapeutics based in?

Palvella Therapeutics is headquartered in United States

When did Palvella Therapeutics go public?

Palvella Therapeutics's initial public offering (IPO) was on January 2, 2015

Is Palvella Therapeutics in the S&P 500?

No, Palvella Therapeutics is not included in the S&P 500 index

Is Palvella Therapeutics in the NASDAQ 100?

No, Palvella Therapeutics is not included in the NASDAQ 100 index

Is Palvella Therapeutics in the Dow Jones?

No, Palvella Therapeutics is not included in the Dow Jones index

When does Palvella Therapeutics report earnings?

The date for Palvella Therapeutics's next earnings report has not been announced yet

Should I buy Palvella Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions